FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2602465663> ?p ?o ?g. }

• W2602465663 endingPage "38425" @default.
• W2602465663 startingPage "38413" @default.
• W2602465663 abstract "// Shuxian Chen 1, * , Xunda Ji 2, * , Ming Liu 1 , Zhengrong Xia 1 , Hui Zheng 1 , Qiufeng Yin 1 , He Wang 3 , Yuhua Li 1 1 Department of Radiology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China 2 Department of Ophthalmology, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai 200092, China 3 Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai 200433, China * These authors have contributed equally to this work Correspondence to: Yuhua Li, email: liyuhua10@sina.com He Wang, email: hewang@fudan.edu.cn Keywords: retinoblastoma, intra-arterial chemotherapy, MRI, ADC value, children Received: December 23, 2016      Accepted: March 14, 2017      Published: March 21, 2017 ABSTRACT Retinoblastoma is the most common intraocular malignant tumor of childhood. Intra-arterial chemotherapy (IAC) is a recently popularized technique used for the treatment of retinoblastoma, to decrease mortality, increase preservation of the eye, and prevent blindness. Along with the extensive use of IAC, it is important to apply noninvasive examination methods to assess the activity of the tumor and the risk factors for disease dissemination without histopathological confirmation. There are few studies that have assessed the value of magnetic resonance imaging (MRI) in evaluating the efficacy and complications of IAC for retinoblastoma. We retrospectively analyzed the MRI features of 60 patients with unilateral retinoblastoma given the primary treatment of IAC from January 2014 to February 2016 in our hospital. Our study showed that MRI could well assess the decreased activity of the tumor after IAC, presenting with diminished tumor size, increased apparent diffusion coefficient (ADC) values (from 0.94 ± 0.24 × 10 −3 mm 2 /s to 2.24 ± 0.40 × 10 −3 mm 2 /s), and a reduced degree of enhancement of the tumor. Our study also showed that MRI can monitor the risk factors of abnormal enhancement of the postlaminar optic nerve, to avoid unnecessary enucleation. Meanwhile, the results showed that the main late complications after IAC included affected eyeball volume reduction, subretinal hemorrhage, vitreous hemorrhage, vitreous opacity, cataractous len, and choroidal vascular ischemia." @default.
• W2602465663 created "2017-04-07" @default.
• W2602465663 creator A5019056174 @default.
• W2602465663 creator A5031355252 @default.
• W2602465663 creator A5044829924 @default.
• W2602465663 creator A5047263441 @default.
• W2602465663 creator A5047264604 @default.
• W2602465663 creator A5071212122 @default.
• W2602465663 creator A5075909785 @default.
• W2602465663 creator A5082763977 @default.
• W2602465663 date "2017-03-21" @default.
• W2602465663 modified "2023-10-16" @default.
• W2602465663 title "The value of MRI in evaluating the efficacy and complications with the treatment of intra-arterial chemotherapy for retinoblastoma" @default.
• W2602465663 cites W1593464380 @default.
• W2602465663 cites W1781263355 @default.
• W2602465663 cites W1966114439 @default.
• W2602465663 cites W1984536924 @default.
• W2602465663 cites W1989632929 @default.
• W2602465663 cites W1999580076 @default.
• W2602465663 cites W2012339246 @default.
• W2602465663 cites W2021155079 @default.
• W2602465663 cites W2025712151 @default.
• W2602465663 cites W2059933096 @default.
• W2602465663 cites W2064499397 @default.
• W2602465663 cites W2069122485 @default.
• W2602465663 cites W2074992065 @default.
• W2602465663 cites W2086993987 @default.
• W2602465663 cites W2090110972 @default.
• W2602465663 cites W2093255707 @default.
• W2602465663 cites W2109825055 @default.
• W2602465663 cites W2111952125 @default.
• W2602465663 cites W2112522939 @default.
• W2602465663 cites W2113150008 @default.
• W2602465663 cites W2116660300 @default.
• W2602465663 cites W2128229751 @default.
• W2602465663 cites W2133738225 @default.
• W2602465663 cites W2134610248 @default.
• W2602465663 cites W2137893806 @default.
• W2602465663 cites W2138475147 @default.
• W2602465663 cites W2141391137 @default.
• W2602465663 cites W2142480746 @default.
• W2602465663 cites W2147379000 @default.
• W2602465663 cites W2161896011 @default.
• W2602465663 cites W2165877780 @default.
• W2602465663 cites W2172143109 @default.
• W2602465663 cites W2278425727 @default.
• W2602465663 cites W2521144285 @default.
• W2602465663 cites W2531110885 @default.
• W2602465663 cites W4211118135 @default.
• W2602465663 cites W4248043920 @default.
• W2602465663 doi "https://doi.org/10.18632/oncotarget.16423" @default.
• W2602465663 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5503542" @default.
• W2602465663 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28415600" @default.
• W2602465663 hasPublicationYear "2017" @default.
• W2602465663 type Work @default.
• W2602465663 sameAs 2602465663 @default.
• W2602465663 citedByCount "14" @default.
• W2602465663 countsByYear W26024656632018 @default.
• W2602465663 countsByYear W26024656632020 @default.
• W2602465663 countsByYear W26024656632021 @default.
• W2602465663 countsByYear W26024656632022 @default.
• W2602465663 countsByYear W26024656632023 @default.
• W2602465663 crossrefType "journal-article" @default.
• W2602465663 hasAuthorship W2602465663A5019056174 @default.
• W2602465663 hasAuthorship W2602465663A5031355252 @default.
• W2602465663 hasAuthorship W2602465663A5044829924 @default.
• W2602465663 hasAuthorship W2602465663A5047263441 @default.
• W2602465663 hasAuthorship W2602465663A5047264604 @default.
• W2602465663 hasAuthorship W2602465663A5071212122 @default.
• W2602465663 hasAuthorship W2602465663A5075909785 @default.
• W2602465663 hasAuthorship W2602465663A5082763977 @default.
• W2602465663 hasBestOaLocation W26024656631 @default.
• W2602465663 hasConcept C104317684 @default.
• W2602465663 hasConcept C118487528 @default.
• W2602465663 hasConcept C126322002 @default.
• W2602465663 hasConcept C126838900 @default.
• W2602465663 hasConcept C143409427 @default.
• W2602465663 hasConcept C143998085 @default.
• W2602465663 hasConcept C185592680 @default.
• W2602465663 hasConcept C2776194525 @default.
• W2602465663 hasConcept C2776577112 @default.
• W2602465663 hasConcept C2776694085 @default.
• W2602465663 hasConcept C502942594 @default.
• W2602465663 hasConcept C55493867 @default.
• W2602465663 hasConcept C71924100 @default.
• W2602465663 hasConceptScore W2602465663C104317684 @default.
• W2602465663 hasConceptScore W2602465663C118487528 @default.
• W2602465663 hasConceptScore W2602465663C126322002 @default.
• W2602465663 hasConceptScore W2602465663C126838900 @default.
• W2602465663 hasConceptScore W2602465663C143409427 @default.
• W2602465663 hasConceptScore W2602465663C143998085 @default.
• W2602465663 hasConceptScore W2602465663C185592680 @default.
• W2602465663 hasConceptScore W2602465663C2776194525 @default.
• W2602465663 hasConceptScore W2602465663C2776577112 @default.
• W2602465663 hasConceptScore W2602465663C2776694085 @default.
• W2602465663 hasConceptScore W2602465663C502942594 @default.
• W2602465663 hasConceptScore W2602465663C55493867 @default.
• W2602465663 hasConceptScore W2602465663C71924100 @default.

• next